Michael Weisman is a Rheumatology/Immunology physician affiliated with Stanford Medicine. OpenAlex indexes 588 publications with 44,609 citations (h-index 94). By OpenAlex citation count, this profile ranks in the top 5% of Rheumatology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8700 Beverly Blvd.
Los Angeles, CA 900481865
Telephone
310-423-2170Registry record last updated 6 Aug 2014.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20241 payment
- Novartis Pharmaceuticals CorporationProgram year20221 payment
- PFIZER INC.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 1985–2010 per NIH RePORTER. The latest:
- A COMPREHENSIVE MODEL OF SEVERITY IN OUTCOMES IN ANKYLOSING SPONDYLITIS
Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
FY2010$211,949M01RR000425 - RHEUMATOID ARTHRITIS ASSOCIATED AUTOIMMUNITY IN HIGH RISK POPULATIONS
Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
FY2010$202,732M01RR000425 - PROJECT 3: DEFINING THE SPECTRUM OF SPONDYLOARTHRITIS IN FAMILY MEMBERS
Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
FY2010$29,489M01RR000425
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
Annals of the Rheumatic Diseases
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Ranjana Advani, MD
Stanford Medicine
Maurice Ohayon, MD, DSC, PhD
Stanford Medicine
Bruno Medeiros, MD
Stanford Medicine
Michael Khodadoust, MD/PHD
Stanford Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”